Protective effects of pergolide in a 6-hydroxydopamine model of Parkinson's disease

被引：0
|
作者：
Ciobica, A.
Hritcu, L.
Artenie, V.
Padurariu, M.
机构：
[1] Alexandru Ioan Cuza Univ, Iasi, Romania
[2] Gr T Popa Univ, Socola Hosp, Iasi, Romania
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P194
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [41] Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease
    Vernon, AC
    Palmer, S
    Datla, KP
    Zbarsky, V
    Croucher, MJ
    Dexter, DT
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (07) : 1799 - 1806
  • [42] Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease
    Black, Yolanda D.
    Xiao, Danqing
    Pellegrino, Daniela
    Kachroo, Anil
    Brownell, Anna-Liisa
    Schwarzschild, Michael A.
    NEUROSCIENCE LETTERS, 2010, 486 (03) : 161 - 165
  • [43] Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease
    Casteels, Cindy
    Lauwers, Erwin
    Bormans, Guy
    Baekelandt, Veerle
    Van Laere, Koen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (01) : 124 - 134
  • [44] Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson's Disease
    Pislar, Anja
    Tratnjek, Larisa
    Glavan, Gordana
    Zivin, Marko
    Kos, Janko
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [45] Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson's disease
    Okkay, Irmak Ferah
    Okkay, Ufuk
    Cicek, Betul
    Yilmaz, Aysegul
    Yesilyurt, Fatma
    Mendil, Ali Sefa
    Hacimuftuoglu, Ahmet
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (12) : 7711 - 7717
  • [46] Paeonol Protection Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Ghalami, Jamileh
    Mojarad, Tourandokht Baluchnejad
    Mansouri, Monireh
    Khamse, Safoura
    Roghani, Mehrdad
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (01) : 43 - 55
  • [47] The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease
    Silvestrin, Roberta Bristot
    de Oliveira, Lucas Fuerstenau
    Batassini, Cristiane
    Oliveira, Alcyr
    Mello e Souza, Tadeu
    JOURNAL OF NEUROSCIENCE METHODS, 2009, 177 (02) : 317 - 321
  • [48] Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease
    Allbutt, Haydn N.
    Henderson, Jasmine M.
    JOURNAL OF NEUROSCIENCE METHODS, 2007, 159 (02) : 195 - 202
  • [49] 6-hydroxydopamine lesions in anuran amphibians: A new model system for Parkinson's disease?
    Endepols, H
    Schul, J
    Gerhardt, HC
    Walkowiak, W
    JOURNAL OF NEUROBIOLOGY, 2004, 60 (04): : 395 - 410
  • [50] Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease
    Ip, Chi Wang
    Beck, Sandra K.
    Volkmann, Jens
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (12) : 1633 - 1643
12345